🏅 FDA Orphan Designation
IXIARO
Japanese encephalitis vaccine, inactivated, adsorbed
Manufacturer: Intercell AG
Indicated for:
Japanese encephalitisOrphan
FDA-Approved Indications (1)
Japanese encephalitisOrphan Designation
IXIARO is a vaccine indicated for the prevention of disease caused by Japanese encephalitis virus (JEV). IXIARO is approved for use in individuals 2 months of age and older.
Indications & Usage
IXIARO is a vaccine indicated for the prevention of disease caused by Japanese encephalitis virus (JEV). IXIARO is approved for use in individuals 2 months of age and older.
Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.